← Evidence map

ArticleCancers2026

Feasibility of Minimally Invasive Surgery After Chemo-Immunotherapy in Locally Advanced and Oligometastatic NSCLC: Technical Aspects and Surgical Outcomes.

Giorgio Cannone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Feasibility of Minimally Invasive Surgery After Chemo-Immunotherapy in Locally Advanced and Oligometastatic NSCLC: Technical Aspects and Surgical Outcomes. | OpenQuestion